TCL Archive ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies July 13, 1984
TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
TCL Archive Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC December 19, 2014
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended May 19, 2000
